Other languages Renalytix Plc Nasdaq

Equities

Real-time Estimate Cboe BZX Other stock markets 12:14:08 2024-07-01 EDT			5-day change	1st Jan Change
0.239 ^USD	+3.46%		-47.76%	-38.77%

06-28	ADRs Advance; Connect Biopharma Holdings Climbs 19%	DJ
06-28	EARNINGS AND TRADING: Thruvision loss widens but Polarean loss narrows	AN

EARNINGS AND TRADING: Thruvision loss widens but Polarean loss narrows	06-28
Renalytix Requests Hearing With Nasdaq to Maintain Listing	06-28
Shares in Renalytix plunge on possible ADS suspension on Nasdaq	06-25
Renalytix to Appeal Nasdaq Delisting Over Non-compliance	06-25
Renalytix's Diabetes, Kidney Disease Test Gets Medicare Final Coverage Determination	06-14
Renalytix Secures Medicare's Final Local Coverage Determination for Kidney Disease Test	06-14
Shares in Renalytix jump as Medicare issues LCD for kidneyintelX.dkd	06-14
Renalytix Files Registration Statement on Behalf of Selling Shareholders	06-06
EXECUTIVE CHANGES: Resolute Mining hires former Acacia exec as chair	05-29
Renalytix Plc Designates Joel R. Jung as Principal Accounting Officer	05-28
Renalytix CFO Steps Down; Interim Successor Named	05-28
Renalytix Plans to Sell American Depositary Shares for Up to $15 Million	05-21
Vertu Motors ups dividend as hails record revenue	05-15
Renalytix Plc Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	05-15
Renalytix chief business officer to become president	04-18
Renalytix plc Announces Executive Changes, Effective from April 30, 2024	04-18
Renalytix Issues New Shares for Convertible Bonds Repayment	04-10
Renalytix announces financing of up to USD4 million	04-08
Renalytix to Raise Up to $4 Million via Share Offering	04-08
Horizonte subsidiary hit with debt injunction	03-14

No results for this search